(Q26772945)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827909%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

review article

1 reference

title

Autoantibody Production in Cancer--The Humoral Immune Response toward Autologous Antigens in Cancer Patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827909%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827909%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Elin S Gray

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827909%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

Mel Ziman

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827909%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

author name string

E S Gray

2

0 references

M R Ziman

3

0 references

language of work or name

English

0 references

publication date

28 January 2016

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827909%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827909%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827909%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827909%20AND%20SRC:MED&resulttype=core&format=json

6 March 2020

page(s)

477-483

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26827909%20AND%20SRC:MED&resulttype=core&format=json

Tumor-induced antibodies resemble the response to tissue damage

6 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Tumor-associated autoantibody signature for the early detection of gastric cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Expression profiles of MUC1, MUC2, and MUC4 mucins in human neoplasms and their relationship with biological behavior

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Regulation of autoreactive B cells: checkpoints and activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

A systematic review of humoral immune responses against tumor antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Dangerous attraction: phagocyte recruitment and danger signals of apoptotic and necrotic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Induction of anti-self-immunity to cure cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Spectra of antinuclear antibodies in patients with squamous cell carcinoma of the lung and of the head and neck.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Death by design: apoptosis, necrosis and autophagy

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Good riddance: Thymocyte clonal deletion prevents autoimmunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Post-translational modifications of self antigens: implications for autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Silencing of autoreactive B cells by anergy: a fresh perspective.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

The abscopal effect associated with a systemic anti-melanoma immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

B-cell self-tolerance in humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Post-translational protein modifications in antigen recognition and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Antinuclear autoantibodies as potential antineoplastic agents

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

The sentinel within: exploiting the immune system for cancer biomarkers

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Protein microarray signature of autoantibody biomarkers for the early detection of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Autoantibody signature for the serologic detection of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Humoral immunity directed against tumor-associated antigens as potential biomarkers for the early diagnosis of cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Oncogenic kinase signalling

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Improving the efficacy of antibody-based cancer therapies

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Cellular and genetic mechanisms of self tolerance and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Disulphide-isomerase-enabled shedding of tumour-associated NKG2D ligands.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Inhibition of follicular T-helper cells by CD8(+) regulatory T cells is essential for self tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Signatures of mutational processes in human cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Mutational landscape and significance across 12 major cancer types

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Harnessing immunity for cancer marker discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Cancer-associated MUC1 mucin inhibits human T-cell proliferation, which is reversible by IL-2

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Cancer genes and the pathways they control

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Cancer/testis antigens, gametogenesis and cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Paradoxical roles of the immune system during cancer development

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

The autoantibody repertoire: searching for order

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Immune response against frameshift-induced neopeptides in HNPCC patients and healthy HNPCC mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Tolerance and autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Autoantibody signatures in prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Therapy-induced antibodies to MHC class I chain-related protein A antagonize immune suppression and stimulate antitumor cytotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Glycosylation defining cancer malignancy: new wine in an old bottle

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Cancer immunomics using autoantibody signatures for biomarker discovery

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Receptor editing: an approach by autoreactive B cells to escape tolerance

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Identification of a novel cancer-specific immunodominant glycopeptide epitope in the MUC1 tandem repeat

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Germinal center checkpoints in B cell tolerance in 3H9 transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

B-cell epitope spreading in autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Autoantibodies to tumor-associated antigens: reporters from the immune system

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Association of the autoimmune disease scleroderma with an immunologic response to cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Does the immune system see tumors as foreign or self?

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

The inflammatory response to cell death

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

The Impact of Autoimmune Diseases on the Incidence and Prognosis of Cutaneous Malignant Melanoma

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

p53 autoantibodies as potential detection and prognostic biomarkers in serous ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Tumor antigen expression in melanoma varies according to antigen and stage

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Immunobiomarkers in small cell lung cancer: potential early cancer signals.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Disruption of CD8+ Treg activity results in expansion of T follicular helper cells and enhanced antitumor immunity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

MFG-E8-mediated uptake of apoptotic cells by APCs links the pro- and antiinflammatory activities of GM-CSF.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Most nuclear systemic autoantigens are extremely disordered proteins: implications for the etiology of systemic autoimmunity

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Anti-Hu antibodies in patients with small-cell lung cancer: association with complete response to therapy and improved survival.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Antibody immunity to the p53 oncogenic protein is a prognostic indicator in ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

The quantity of TCR signal determines positive selection and lineage commitment of T cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021

Tumor-infiltrating B cells: The ignored players in tumor immunology.

1 reference

https://api.crossref.org/works/10.1016%2FJ.AUTREV.2016.01.017

7 January 2021